1 Start 2 Complete
Overall, how would you rate this series?
Discuss molecular pathways of solid tumors (glioma, melanoma, colon, lung, thyroid, etc.) and hematologic malignancy.
Integrate molecular findings with morphology and clinical information.
Demonstrate diagnostic, prognostic, and therapeutic property of each alteration in the gene detected.
Consensus conference of the calling alterations with respect to a disease and the ethnicity of the patient.
Identify available clinical trials for the specific alterations.
Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
Fair & Balanced
Free of Commercial Bias